yes it will be great having a $42b daddy.
if the trials go well and everything goes accordingy to plan, they may attempt to mop up the remaining 80% - if not at least they are committed to stem cells and the relationship with mesoblast is in tact.
lets see if any other big pharma is interested in cephalon - or why not go straight for mesoblast if that is the big potential.
MSB is near its peak in a p8ss weak market - pretty good and again this is on no news!
teva bets on msb stem cells , page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |